113 related articles for article (PubMed ID: 28098869)
1. Core‑shell lipid polymer nanoparticles for combined chemo and gene therapy of childhood head and neck cancers.
Zhang T; Ma J; Li C; Lin K; Lou F; Jiang H; Gao Y; Yang Y; Ming C; Ruan B
Oncol Rep; 2017 Mar; 37(3):1653-1661. PubMed ID: 28098869
[TBL] [Abstract][Full Text] [Related]
2. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
3. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
6. Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin.
Qu J; Liu Y; Yu Y; Li J; Luo J; Li M
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():166-74. PubMed ID: 25280693
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
Zhang Y; Zhang P; Zhu T
Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Xu Y; Han X; Li Y; Min H; Zhao X; Zhang Y; Qi Y; Shi J; Qi S; Bao Y; Nie G
ACS Nano; 2019 Nov; 13(11):13445-13455. PubMed ID: 31670945
[TBL] [Abstract][Full Text] [Related]
10. Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines.
Wang M; Miura Y; Tsuchihashi K; Miyano K; Nagano O; Yoshikawa M; Tanabe A; Makino J; Mochida Y; Nishiyama N; Saya H; Cabral H; Kataoka K
J Control Release; 2016 May; 230():26-33. PubMed ID: 27040816
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers.
He C; Liu D; Lin W
ACS Nano; 2015 Jan; 9(1):991-1003. PubMed ID: 25559017
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB
Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059
[TBL] [Abstract][Full Text] [Related]
15. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
[TBL] [Abstract][Full Text] [Related]
16. Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
Gargouri M; Sapin A; Bouli S; Becuwe P; Merlin JL; Maincent P
Technol Cancer Res Treat; 2009 Dec; 8(6):433-44. PubMed ID: 19925027
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared light stimuli-responsive synergistic therapy nanoplatforms based on the coordination of tellurium-containing block polymer and cisplatin for cancer treatment.
Li F; Li T; Cao W; Wang L; Xu H
Biomaterials; 2017 Jul; 133():208-218. PubMed ID: 28441615
[TBL] [Abstract][Full Text] [Related]
18. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
19. Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles.
Yen YT; Wang X; Zhang H; Wang C; Lin Z; Xie C; Liu Q; Wang L; Yu L; Li X; Lv X; Liu B; Li R
J Biomed Nanotechnol; 2020 Mar; 16(3):335-343. PubMed ID: 32493543
[TBL] [Abstract][Full Text] [Related]
20. Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy.
Guo S; Wang Y; Miao L; Xu Z; Lin CM; Zhang Y; Huang L
ACS Nano; 2013 Nov; 7(11):9896-904. PubMed ID: 24083505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
